Is overall mortality the right composite endpoint in clinical trials of acute respiratory distress syndrome?

Critical Care Medicine

Volumn 46, Issue 6, 2018, Pages 892-899

  Villar, Jesús ^a,b   Martínez, Domingo ^c   Mosteiro, Fernando ^d   Ambrós, Alfonso ^e   Añón, José M ^a,f   Ferrando, Carlos ^a,g   Soler, Juan A ^c   Montiel, Raquel ^h   Vidal, Anxela ⁱ   Conesa Cayuela, Luís A ^c   Blanco, Jesús ^a,j   Arrojo, Regina ^d   Solano, Rosario ^k   Capilla, Lucía ^l   Del Campo, Rafael ^e   Civantos, Belén ^f   Fernández, María Mar ^m   Aldecoa, César ^j   Parra, Laura ⁿ   Gutiérrez, Andrea ^g   Martínez Jiménez, Chanel ^o   González Martín, Jesús M ^b   Fernández, Rosa L ^a,b   Kacmarek, Robert M ^p,q   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d UNIVERSITY OF A CORUÑA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^h HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^j HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^k HOSPITAL VIRGEN DE LA LUZ   (Spain)

^l HOSPITAL MORALES MESEGUER   (Spain)

^m HOSPITAL MÚTUA DE TERRASSA   (Spain)

ⁿ HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^o HOSPITAL EL BIERZO   (Spain)

^p MASSACHUSETTS GENERAL HOSPITAL   (United States)

^q HARVARD UNIVERSITY   (United States)

more..

Author keywords

Acute respiratory distress syndrome; Aging; Composite endpoint; Multiple organ failure; Outcome

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALL CAUSE MORTALITY; ARTICLE; ARTIFICIAL VENTILATION; BRAIN INJURY; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; FEMALE; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS; RISK FACTOR; SECONDARY ANALYSIS; STATISTICAL ANALYSIS; CLINICAL TRIAL; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CAUSE OF DEATH; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 85051732189     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000003022     Document Type: Article

References (48)

1. Schulz K: When things go missing. New York, The New Yorker, 2017
2. Villar J, Blanco J, Kacmarek RM: Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care 2016; 22: 1-6
3. Villar J, Blanco J, Añón JM, et al; ALIEN Network: The ALIEN study: Incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med 2011; 37: 1932-1941
4. Villar J, Ambrós A, Soler JA, et al; Stratification and Outcome of Acute Respiratory Distress Syndrome (STANDARDS) Network: Age, Pao2/Fio2, and Plateau Pressure Score: A proposal for a simple outcome score in patients with the acute respiratory distress syndrome. Crit Care Med 2016; 44: 1361-1369
5. Villar J, Fernández RL, Ambrós A, et al; Acute Lung Injury Epidemiology and Natural history Network: A clinical classification of the acute respiratory distress syndrome for predicting outcome and guiding medical therapy. Crit Care Med 2015; 43: 346-353
6. Villar J, Slutsky AS: GOLDEN anniversary of the acute respiratory distress syndrome: Still much work to do! Curr Opin Crit Care 2017; 23: 4-9
7. Villar J, Manzano JJ, Blazquez MA, et al: Multiple system organ failure in acute respiratory failure. J Crit Care 1991; 6: 75-80
8. Bosslet GT, Pope TM, Rubenfeld GD, et al; American Thoracic Society ad hoc Committee on Futile and Potentially Inappropriate Treatment; American Thoracic Society; American Association for Critical Care Nurses; American College of Chest Physicians; European Society for Intensive Care Medicine; Society of Critical Care: An official ATS/AACN/ACCP/ESICM/SCCM policy statement: Responding to requests for potentially inappropriate treatments in intensive care units. Am J Respir Crit Care Med 2015; 191: 1318-1330
9. Villar J, Pérez-Méndez L, López J, et al; HELP Network: An early PEEP/Fio2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2007; 176: 795-804
10. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824
11. Ranieri VM, Rubenfeld GD, Thompson BT, et al; The ARDS Definition Task Force: Acute respiratory distress syndrome. The Berlin definition. JAMA 2012; 307: 2526-2533
12. Vincent JL, de Mendonça A, Cantraine F, et al: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-1800
13. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Crit Care Med 2003; 31: 1250-1256
14. Mitnitski A, Song X, Rockwood K: Assessing biological aging: The origin of deficit accumulation. Biogerontology 2013; 14: 709-717
15. European Medicines Agency: Points to Consider on Frailty: Evaluation Instruments for Baseline Characterization of Clinical Trial Populations. 2015. Available at: http://aginginmotion. org/wp-content/uploads/2016/03/EMA-Frailty. pdf. Accessed December 16, 2015
16. Kacmarek RM, Villar J, Sulemanji D, et al; Open Lung Approach Network: Open lung approach for the acute respiratory distress syndrome: A pilot, randomized controlled trial. Crit Care Med 2016; 44: 32-42
17. Tonelli AR, Zein J, Adams J, et al: Effects of interventions on survival in acute respiratory distress syndrome: An umbrella review of 159 published randomized trials and 29 meta-analyses. Intensive Care Med 2014; 40: 769-787
18. Villar J, Belda J, Añón JM, et al; DEXA-ARDS Network: Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: Study protocol for a randomized controlled trial. Trials 2016; 17: 342
19. Pirrone M, Fisher D, Chipman D, et al: Recruitment maneuvers and positive end-expiratory pressure titration in morbidly obese ICU patients. Crit Care Med 2016; 44: 300-307
20. Ely EW, Wheeler AP, Thompson BT, et al: Recovery rate and prognosis in older persons who develop acute lung injury and the acute respiratory distress syndrome. Ann Intern Med 2002; 136: 25-36
21. Cochi SE, Kempker JA, Annangi S, et al: Mortality trends of acute respiratory distress syndrome in the United States from 1999 to 2013. Ann Am Thorac Soc 2016; 13: 1742-1751
22. Conquhoun D: An investigation of the false discovery rate and the misinterpretation of p-values. R Soc Open Sci 2014; 1: 140216
23. Villar J, Pérez-Méndez L, Aguirre-Jaime A, et al: Why are physicians so skeptical about positive randomized controlled clinical trials in critical care medicine? Intensive Care Med 2005; 31: 196-204
24. Montgomery AB, Stager MA, Carrico CJ, et al: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132: 485-489
25. Suchyta MR, Clemmer TP, Elliott CG, et al: The adult respiratory distress syndrome. A report of survival and modifying factors. Chest 1992; 101: 1074-1079
26. McLean RF, Tarshis J, Mazer CD, et al: Death in two Canadian intensive care units: institutional difference and changes over time. Crit Care Med 2000; 28: 100-103
27. Stapleton RD, Wang BM, Hudson LD, et al: Causes and timing of death in patients with ARDS. Chest 2005; 128: 525-532
28. Martin GS: Temporal changes in clinical outcomes with ARDS. Chest 2005; 128: 479-481
29. Herrán-Monge R, Muriel-Bombín A, García-García M, et al: Epidemiology and changes in mortality of sepsis alter the implementation of surviving campaign guidelines. J Intensive Care Med 2017 Jan 1. [Epub ahead of print]
30. Nuytinck JK, Goris RJ: Pathophysiology of the adult respiratory distress syndrome (ARDS) and multiple organ failure (MOF)-a hypothesis. Neth J Surg 1985; 37: 131-136
31. Villar J, Slutsky AS: Ventilator management of sepsis-associated respiratory distress syndrome. In: Sepsis and Multiorgan Failure. Fein AM, Abraham EM, Balk RA, et al (Eds), Baltimore, MD, William & Wilkins, 1997, pp 453-461
32. Villar J, Blazquez MA, Lubillo S, et al: Septic shock and acute respiratory failure. Prog Clin Biol Res 1989; 308: 61-65
33. Villar J, Blanco J, Zhang H, et al: Ventilator-induced lung injury and sepsis: Two sides of the same coin? Minerva Anestesiol 2011; 77: 647-653
34. Reinhart K, Daniels R, Kissoon N, et al: Recognizing sepsis as a global health priority-A WHO resolution. N Engl J Med 2017; 377: 414-417
35. López-Otín C, Blasco MA, Partridge L, et al: The hallmarks of aging. Cell 2013; 153: 1194-1217
36. Weiss ST: Lung function and airway diseases. Nat Genet 2010; 42: 14-16
37. Herrera AP, Snipes SA, King DW, et al: Disparate inclusion of older adults in clinical trials: Priorities and opportunities for policy and practice change. Am J Public Health 2010; 100(Suppl 1): S105-S112
38. Zhavoronkov A, Bhullar B: Classifying aging as a disease in the context of ICD-11. Front Genet 2015; 6: 326
39. Orimo H: Reviewing the definition of elderly. Nihon Ronen Igakkai Zasshi 2006; 43: 27-34
40. Green D, Cushman M, Dermond N, et al: Obtaining informed consent for genetic studies: The multiethnic study of atherosclerosis. Am J Epidemiol 2006; 164: 845-851
41. Tattersall MH, Jefford M, Martin A, et al: Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials. BMJ Open 2017; 7: e012666
42. Brower RG, Matthay MA, Morris A, et al; Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342: 1301-1308
43. Hayden D, Schoenfeld D, Bernard G, et al: Outcome of participants vs. eligible participants in clinical trial of critically ill patients (abstract). Am J Respir Crit Care Med 2000; 161: A210
44. Najafzadeh M, Schneeweiss S: From trial to target populations-calibrating real-world data. N Engl J Med 2017; 376: 1203-1205
45. Villar J, Pérez-Méndez L, Kacmarek RM: The Berlin definition met our needs: No. Intensive Care Med 2016; 42: 648-650
46. Papazian L, Forel JM, Gacouin A, et al; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363: 1107-1116
47. Guérin C, Reignier J, Richard JC, et al; PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368: 2159-2168
48. Villar J, Kacmarek RM, Guérin C: Clinical trials in patients with the acute respiratory distress syndrome: Burn after reading. Intensive Care Med 2014; 40: 900-902